Why is the UK subscription model for antibiotics considered successful?
R. E. Glover, Andrew C. Singer, Adam P. Roberts, Claas Kirchhelle
Abstract
Defining success is a crucial component of policy delivery, for where public funds are disbursed, public benefit should follow. Sometimes, the desire to proclaim success and international leadership can precede robust policy evaluation, for reasons of political economy, or in response to a need for a policy win. Since July, 2023, such discourse around the desire for success has developed around the UK's subscription scheme for new antibiotics.
Topics & Concepts
AntibioticsComputer scienceMicrobiologyBiologyAntibiotic Use and ResistanceBacterial Identification and Susceptibility TestingPharmaceutical industry and healthcare